Wegovy Where To Buy

Wegovy Where To Buy. Wegovy (semaglutide) is an injectable weight-reduction medication used for obese adults and adolescents, as well as overweight people with other weight-related medical conditions. Wegovy is a GLP-1 agonist that works by mimicking the hormone glucagon-like peptide-1 (GLP-1) and activating the GLP-1 receptors, hence regulating hunger and food intake. Wegovy should be taken in conjunction with a reduced-calorie diet and increased physical exercise to aid in weight loss. Wegovy Where To Buy. Once each week, Wegovy is administered subcutaneously (subcutaneous injection). Wegovy includes semaglutide, the same active component found in Ozempic and Rybelsus; hence, these medications should not be used together. Ozempic (weekly subcutaneous injection) and Rybelsus (a daily pill) are used to reduce blood sugar levels in people with type 2 diabetes. Ozempic is also used to reduce the risk of significant cardiovascular events in some people with type 2 diabetes. Wegovy should not be taken in conjunction with other GLP-1 receptor agonists.

What is Wegovy used for?

Wegovy is an FDA-approved anti-obesity medicine to be used by people 12 years and older for chronic weight management when used together with a reduced-calorie diet and increased physical activity. Wegovy is indicated for use in:

Adults:

• Obese (BMI of 30 kg/m2 or greater)
• Overweight (BMI of 27 kg/m2 or greater) and have medical problems due to your weight.

Pediatric (12 years and older):

• Obese (initial BMI 95th percentile or greater for age and sex)

Important information

Wegovy may cause serious side effects, including:

• Possible thyroid tumors, including cancer. It is important to tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy and medicines that work like Wegovy caused thyroid tumors, including thyroid cancer. It is not known if Wegovy will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
• Do not use this medicine if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC), or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Who should not use Wegovy?

Wegovy should not be used by you if:

• Have you or any of your family ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• you have had a serious allergic reaction to dulaglutide or any of the ingredients. See the end of this page for a complete list of ingredients. Symptoms of a serious allergic reaction include:
  • swelling of your face, lips, tongue, or throat
  • problems breathing or swallowing
  • severe rash or itching
  • fainting or feeling dizzy
  • very rapid heartbeat

Pregnancy and breastfeeding:

• If you plan to become pregnant or are pregnant. Wegovy may harm your unborn baby. You should stop using this medicine 2 months before you plan to become pregnant.
  • Pregnancy Exposure Registry: There is a pregnancy exposure registry for women who use Wegovy during pregnancy. The purpose of this registry is to collect information about the health of you and your baby.
    Talk to your healthcare provider about how you can take part in this registry or you may contact Novo Nordisk at 1-800-727-6500.
• If you plan to breastfeed or are breastfeeding. It is not known if Wegovy passes into your breast milk. You should talk with your healthcare provider about the best way to feed your baby while using this medicine.

How should I use Wegovy?

Read the Instructions for Use that is with your prescription and use this medicine exactly as your healthcare provider tells you to. Your healthcare provider should train you on how to use this medicine before you start using it.

• Wegovy is injected under the skin (subcutaneously) of your stomach (abdomen), thigh, or upper arm. You should not inject this medicine into a muscle (intramuscularly) or vein (intravenously).
• Rotate your injection site with each injection. You should not use the same site for each injection.
• Wegovy should be used one time each week, on the same day each week, at any time of the day.
• You can take Wegovy with or without food.
• Usual Dose for Weight Loss:
  • Initial Dose Escalation Schedule:
  • Weeks 1 through 4 (month one): 0.25 mg subcutaneously once a week
  • Weeks 5 through 8 (month two): 0.5 mg subcutaneously once a week
  • Weeks 9 through 12 (month three): 1 mg subcutaneously once a week
  • Weeks 13 through 16 (month four): 1.7 mg subcutaneously once a week
  • Maintenance Dose:
  • Week 17 and onward: 2.4 mg subcutaneously once a week
• Maintenance Dosage Adult Patients. The maintenance dosage is 2.4 mg injected subcutaneously once weekly. If the patient does not tolerate the maintenance 2.4 mg once-weekly dosage, then the dosage can be temporarily decreased to 1.7 mg once a week, for a maximum of 4 weeks. After 4 weeks, the dose should be increased to the maintenance 2.4 mg once-weekly dosage. Discontinue this medicine if the patient cannot tolerate the 2.4 mg dosage.
• Pediatric Patients Aged 12 Years and Older. The recommended maintenance dosage of Wegovy is 2.4 mg injected subcutaneously once weekly. If the patient does not tolerate the maintenance 2.4 mg once-weekly dosage, the maintenance dosage may be reduced to 1.7 mg once weekly. Discontinue this medicine if the patient cannot tolerate the 1.7 mg dose.

What happens if I overdose?

• If you take too much Wegovy, you may have severe nausea, severe vomiting, and severely low blood sugar. Call your healthcare provider or go to the nearest hospital emergency room right away if you experience any of these symptoms.

What happens if I miss a dose?

• If you miss your Wegovy dose and the next scheduled dose is more than 2 days away (48 hours), then take the missed dose as soon as possible. If you miss a dose and the next scheduled dose is less than 2 days away (48 hours), do not administer the dose. Instead, take your next dose on the regularly scheduled day.
• If you miss your Wegovy doses for more than 2 weeks, take your next dose on the regularly scheduled day or call your healthcare provider to talk about how to restart your treatment.

What strengths is Wegovy available in?

Wegovy is available in five strengths:

• Wegovy 0.25 mg (semaglutide)
• Wegovy 0.5 mg (semaglutide)
• Wegovy 1 mg (semaglutide)
• Wegovy 1.7 mg (semaglutide)
• Wegovy 2.4 m(semaglutide)

Wegovy side effects

Wegovy may cause serious side effects, including:

• also, see Important information in the section above.
• inflammation of your pancreas (pancreatitis). Stop using Wegovy and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.
• gallbladder problems. Wegovy may cause gallbladder problems including gallstones. Some gallbladder problems need surgery. Call your healthcare provider if you have any of the following symptoms:
  • pain in your upper stomach (abdomen)
  • fever
  • yellowing of skin or eyes (jaundice)
  • clay-colored stools
• increased risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes, especially those who also take medicines to treat type 2 diabetes mellitus such as sulfonylureas or insulin. Low blood sugar in patients with type 2 diabetes who receive this medicine can be both a serious and common side effect. Talk to your healthcare provider about how to recognize and treat low blood sugar. You should check your blood sugar before you start, and during treatment. Signs and symptoms of low blood sugar may include:
  • dizziness or light-headedness
  • blurred vision
  • anxiety
  • irritability or mood changes
  • sweating
  • slurred speech
  • hunger
  • confusion or drowsiness
  • shakiness
  • weakness
  • headache
  • fast heartbeat
  • feeling jittery
• kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration) which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration.
• serious allergic reactions. Stop using this medicine and get medical help right away, if you have any symptoms of a serious allergic reaction including:
  • swelling of your face, lips, tongue or throat
  • problems breathing or swallowing
  • severe rash or itching
  • fainting or feeling dizzy
  • very rapid heartbeat
• change in vision in people with type 2 diabetes. Tell your healthcare provider if you have changes in vision during treatment.
• increased heart rate. Wegovy can increase your heart rate while you are at rest. Your healthcare provider should check your heart rate while you take Wegovy. Tell your healthcare provider if you feel your heart racing or pounding in your chest and it lasts for several minutes.
• depression or thoughts of suicide. You should pay attention to any mental changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Call your healthcare provider right away if you have any mental changes that are new, worse, or worry you.

The most common Wegovy side effects may include:

• nausea
• diarrhea
• vomiting
• constipation
• stomach (abdomen) pain
• headache
• tiredness (fatigue)
• upset stomach
• dizziness
• feeling bloated
• belching
• gas
• stomach flu
• heartburn

Talk to your healthcare provider about any side effect that bothers you or does not go away. These are not all the possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Wegovy?

Wegovy may impede digestion, making it more difficult for the body to absorb medications taken orally. Inform your doctor of any other medications you are taking, notably insulin and other diabetic medications such as dulaglutide, exenatide, liraglutide, Byetta, Trulicity, and Victoza. Wegovy may interact with prescription and over-the-counter medications, vitamins, and herbal preparations. Inform your doctor of any other medications you are taking.

Storage 

Wegovy single-dose pen:

• Wegovy should be stored in a refrigerator from 2°C to 8°C (36°F to 46°F).
• If needed (prior to cap removal) the pen can be kept from 8°C to 30°C (46°F to 86°F) up to 28 days.
• Do not freeze.
• Protect Wegovy from light. Wegovy must be kept in the original carton until time of administration. Discard the Wegovy pen after use.

What are the ingredients in Wegovy?

• Active Ingredient: semaglutide
• Inactive Ingredients: disodium phosphate dihydrate, sodium chloride, and water for injection
• Wegovy is Manufactured by: Novo Nordisk A/S. Novo Allé. DK-2880 Bagsvaerd, Denmark.